alendronate has been researched along with Menopause in 11 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was designed to evaluate the relationship of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on salivary flow rate, saliva pH, and electrolytes." | 7.73 | The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. ( Gurgan, S; Gurgan, T; Yalçin, F, 2005) |
| "The study was designed to evaluate the relationship of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on salivary flow rate, saliva pH, and electrolytes." | 3.73 | The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. ( Gurgan, S; Gurgan, T; Yalçin, F, 2005) |
| "Treatment with alendronate decreased both urinary markers of bone resorption (pyridinolines, hydroxyproline, and calcium) and serum markers of bone formation (osteocalcin and alkaline phosphatase) in a dose-dependent fashion." | 2.67 | The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. ( Chesnut, CH; DeBrock, J; Eyre, DR; Genant, HK; Gertz, BJ; Harris, ST; Ricerca, E; Survill, TT; Ventura, JN, 1993) |
| "Many women now survive breast cancer, but find themselves at increased risk of menopausal complications." | 1.31 | Managing menopause after breast cancer: balancing risks and benefits. ( Moore, HC, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Yoon, BK | 1 |
| Citraro, R | 1 |
| Gallelli, L | 1 |
| Leo, A | 1 |
| De Fazio, P | 1 |
| Gallelli, P | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Lai, PS | 1 |
| Chua, SS | 1 |
| Chew, YY | 1 |
| Chan, SP | 1 |
| Fukunaga, M | 1 |
| Toro, J | 1 |
| Gentil, MA | 1 |
| García, R | 1 |
| Pérez-Valdivia, MA | 1 |
| García Avellano, E | 1 |
| Algarra, GR | 1 |
| Pereira, P | 1 |
| González-Roncero, F | 1 |
| Mateos, J | 1 |
| Yalçin, F | 1 |
| Gurgan, S | 1 |
| Gurgan, T | 1 |
| d'Arailh, AS | 1 |
| Lopes, P | 1 |
| Harris, ST | 1 |
| Gertz, BJ | 1 |
| Genant, HK | 1 |
| Eyre, DR | 1 |
| Survill, TT | 1 |
| Ventura, JN | 1 |
| DeBrock, J | 1 |
| Ricerca, E | 1 |
| Chesnut, CH | 1 |
| Bonde, M | 1 |
| Garnero, P | 1 |
| Fledelius, C | 1 |
| Qvist, P | 1 |
| Delmas, PD | 1 |
| Christiansen, C | 1 |
| Moore, HC | 1 |
3 reviews available for alendronate and Menopause
| Article | Year |
|---|---|
The impacts of menopausal hormone therapy on longer-term health consequences of ovarian hormone deficiency.
Topics: Alendronate; Estradiol; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Menopause; Pr | 2023 |
[Bone mass measurement and evaluation of therapeutical response].
Topics: Absorptiometry, Photon; Aging; Alendronate; Biomarkers; Bone Density; Calcium; Estrogen Replacement | 2004 |
[Menopause].
Topics: Age Factors; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Densitometry; Estrog | 2006 |
4 trials available for alendronate and Menopause
| Article | Year |
|---|---|
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
Topics: Alendronate; Biomarkers, Pharmacological; Bone and Bones; Bone Density; Bone Density Conservation Ag | 2011 |
Alendronate in kidney transplant patients: a single-center experience.
Topics: Alendronate; Body Weight; Bone Density; Calcium; Female; Humans; Lumbar Vertebrae; Male; Menopause; | 2005 |
The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.
Topics: Adult; Alendronate; Biomarkers; Blood; Bone Density; Bone Remodeling; Diphosphonates; Dose-Response | 1993 |
New drugs for osteoporosis.
Topics: Administration, Intranasal; Aged; Alendronate; Calcitonin; Calcium; Costs and Cost Analysis; Delayed | 1996 |
4 other studies available for alendronate and Menopause
| Article | Year |
|---|---|
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model.
Topics: Alendronate; Animals; Anxiety; Depression; Female; Menopause; Models, Animal; Rats; Rats, Wistar | 2015 |
The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
Topics: Adult; Alendronate; Analysis of Variance; Bone Density Conservation Agents; Calcium; Case-Control St | 2005 |
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
Topics: Adult; Alendronate; Amino Acid Sequence; Antibodies; Biomarkers; Bone Resorption; Collagen; Collagen | 1997 |
Managing menopause after breast cancer: balancing risks and benefits.
Topics: Adult; Alendronate; Antidepressive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Calcit | 2001 |